Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
Apostolia Papalexandri(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Chrysaygi Lalayanni(American Institute of Biological Sciences), Μαρία Παπαθανασίου(Goethe University Frankfurt), Anastasia Athanasiadou, Maria-Georgia Koutra(American Institute of Biological Sciences), Eirini Baldoumi(American Institute of Biological Sciences), Tasoula Touloumenidou(G. Papanikolaou General Hospital), Riad Saloum(American Institute of Biological Sciences), Panagiota Zerva(American Institute of Biological Sciences)
Cited by 22
Related Papers
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63
Beta-thalassemia: renal complications and mechanisms: a narrative review
|Hematology|2019|62